Submitted by Anonymous (not verified) on 25 September 2025 - 13:09
Human medicines European public assessment report (EPAR): Xaluprine (previously Mercaptopurine Nova Laboratories), mercaptopurine, Date of authorisation: 09/03/2012, Revision: 19, Status: Authorised
Source: